Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Common Equity (2016 - 2025)

National Research (NRC) has disclosed Common Equity for 16 consecutive years, with $14.0 million as the latest value for Q4 2025.

  • Quarterly Common Equity fell 55.28% to $14.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.0 million through Dec 2025, down 55.28% year-over-year, with the annual reading at $14.0 million for FY2025, 55.28% down from the prior year.
  • Common Equity hit $14.0 million in Q4 2025 for National Research, down from $14.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $85.3 million in Q4 2021 to a low of $14.0 million in Q4 2025.
  • Historically, Common Equity has averaged $54.5 million across 5 years, with a median of $62.8 million in 2022.
  • Biggest five-year swings in Common Equity: surged 96.4% in 2021 and later plummeted 58.66% in 2025.
  • Year by year, Common Equity stood at $85.3 million in 2021, then decreased by 15.59% to $72.0 million in 2022, then crashed by 32.04% to $49.0 million in 2023, then tumbled by 36.1% to $31.3 million in 2024, then crashed by 55.28% to $14.0 million in 2025.
  • Business Quant data shows Common Equity for NRC at $14.0 million in Q4 2025, $14.3 million in Q3 2025, and $21.3 million in Q2 2025.